Although the variant in our patient was not evaluated using an in vitro assay, its high similarity to previously reported pathogenic variants strongly suggests that the variant protein exerts a dominant-negative effect, impairing GCM2 function and leading to hypoparathyroidism. Here, GCM2 is linked to hypoparathyroidism.